Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Nov 9;12(1):1-14.
doi: 10.1080/19490976.2020.1814107. Epub 2020 Sep 8.

Young versus aged microbiota transplants to germ-free mice: increased short-chain fatty acids and improved cognitive performance

Affiliations

Young versus aged microbiota transplants to germ-free mice: increased short-chain fatty acids and improved cognitive performance

Juneyoung Lee et al. Gut Microbes. .

Abstract

Aging is associated with cognitive decline and decreased concentrations of short-chain fatty acids (SCFAs) in the gut. SCFAs are significant in that they are protective to the gut and other organs. We tested the hypothesis that the aged gut microbiome alone is sufficient to decrease SCFAs in the host and produce cognitive decline. Fecal transplant gavages (FTGs) from aged (18-20 months) or young (2-3 months) male C57BL/6 mice into germ-free male C57BL/6 mice (N = 11 per group) were initiated at ~3 months of age. Fecal samples were collected and behavioral testing was performed over the study period. Bacterial community structures and relative abundances were measured in fecal samples by sequencing the bacterial 16S ribosomal RNA gene. Mice with aged and young microbiomes showed clear differences in bacterial β diversity at 30, 60, and 90 d (P = .001 for each) after FTGs. The fecal SCFAs, acetate, propionate, and butyrate (microbiome effect, P < .01 for each) were decreased in mice with an aged microbiome. Mice with an aged microbiome demonstrated depressive-like behavior, impaired short-term memory, and impaired spatial memory over the 3 months following the initial FTG as assessed by the tail suspension (P = .008), the novel object recognition (P < .001), and the Barnes Maze (P = .030) tests, respectively. We conclude that an aged microbiome alone is sufficient to decrease SCFAs in the host and to produce cognitive decline.

Keywords: Aging; acetate; butyrate; cognitive decline; germ-free mice; gut microbiome; inflammation; propionate; short-chain fatty acids.

PubMed Disclaimer

Conflict of interest statement

No financial interest or benefit has arisen from the direct application of this research. The authors report no conflict of interest.

Figures

Figure 1.
Figure 1.
The time line for the studies in germ-free mice. Following FTG (fecal transplant gavage) mice with young and aged FTG were housed separately in a conventional animal holding room
Figure 2.
Figure 2.
Principal component analyses (PCAs) of the Aitchison distance, a measure of beta diversity, in mice with young and aged microbiomes at 30, 60, and 90 d after the initial fecal transplant gavage. PERMANOVA F statistics and P value is within each plot. The aged group at 30 d (top panel, depicted by arrow pointing to the group centroid) has data points that cluster into two groups. This clustering is discussed in the manuscript
Figure 3.
Figure 3.
Differential abundance of taxa from GF mice after fecal transplant gavage with an aged or young gut microbiome. Only taxa showing P < .2 in at least one of the time points were displayed. Statistical analysis was conducted after a centered log-ratio transformation using Kruskal–Wallis test with post hoc Benjamini-Hochberg correction. N = 11 per group. * and ** P < .05 and 0.01 respectively
Figure 4.
Figure 4.
Heat map of relative abundance for bacterial enzymes used in the metabolism of acetate, propionate, and butyrate. Predictions were made from feces of mice collected 30, 60, and 90 d after the initial fecal transp gavage using data from 16S ribosomal RNA gene analysis and the software program, PICRUSt2. *, **, and *** P < .05, <0.01, and <0.001 respectively, N = 11 per group)
Figure 5.
Figure 5.
Changes in SCFA concentrations in fecal samples of mice with aged and young gut microbiomes. The “0” time point represents concentrations in the GF mice before fecal transp gavage. Note the “0” time point was not used in the statistical analysis. Data for individual SCFAs were normalized to the value obtained in the “30 day” group having a young microbiome. Significant main effects of the microbiome (aged or young) when present are shown in each graph. * P < .05 compared to the young microbiome of the same time point (Holm-Sidak post hoc test, N = 11 per group). See Supplemental Table I for more statistical details. Note that the SCFAs in the 30 d aged group showed a dichotomy as described under beta diversity above. Dichotomy in the SCFAs did not occur in any other group
Figure 6.
Figure 6.
The effects of aged or young gut microbiome on short-term memory recall using the novel object recognition test (NORT). Duration of time spent at the novel object as a percent of the total time. Significant main effect of gut microbiome using 2 way repeated measures ANOVA P < .001, N = 10–11. *, ** P < .05 and <0.001 compared to young biome of the same time (post hoc Holm-Sidak test). See Supplemental Table I for more statistical details. Note: one mouse with an aged microbiome failed to explore at 60 d and was omitted from the analysis
Figure 7.
Figure 7.
(a) Tail suspension test and (b) Barnes Maze. There was a significant main effect of the gut microbiome (P = .008 and 0.030 for A and B respectively, (N = 9–11). *,** P < .05 and 0.001 compared to young biome at the same time point (Holm-Sidak post hoc analysis). See Supplemental Table I for more statistical details. Note that the time of immobility in the 30 d aged group showed a dichotomy as described in the text. None of the other behavioral tests regardless of time after the initial gavage showed a dichotomy

Similar articles

Cited by

References

    1. Zapata HJ, Quagliarello VJ.. The microbiota and microbiome in aging: potential implications in health and age-related diseases. J Am Geriatr Soc. 2015. April;63(4):776–781. doi: 10.1111/jgs.13310. - DOI - PMC - PubMed
    1. Vaiserman AM, Koliada AK, Marotta F. Gut microbiota: a player in aging and a target for anti-aging intervention. Ageing Res Rev. 2017. January;18(35):36–45. doi: 10.1016/j.arr.2017.01.001. - DOI - PubMed
    1. Buford TW. (Dis)Trust your gut: the gut microbiome in age-related inflammation, health, and disease. Microbiome. 2017. July 14;5(1):80. doi: 10.1186/s40168-017-0296-0. - DOI - PMC - PubMed
    1. Borre YE, O’Keeffe GW, Clarke G, Stanton C, Dinan TG, Cryan JF. Microbiota and neurodevelopmental windows: implications for brain disorders. Trends Mol Med. 2014. September;20(9):509–518. doi: 10.1016/j.molmed.2014.05.002. - DOI - PubMed
    1. Cryan JF, O’Riordan KJ, Cowan CSM, Sandhu KV, Bastiaanssen TFS, Boehme M, Codagnone MG, Cussotto S, Fulling C, Golubeva AV, et al. The microbiota-gut-brain axis. Physiol Rev. 2019. October 1;99(4):1877–2013. - PubMed

Publication types

MeSH terms